Authors:
Frenkel, J
Houten, SM
Waterham, HR
Wanders, RJA
Rijkers, GT
Duran, M
Kuijpers, TW
van Luijk, W
Poll-The, BT
Kuis, W
Citation: J. Frenkel et al., Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D, RHEUMATOLOG, 40(5), 2001, pp. 579-584
Authors:
van den Berg, JM
Weyer, S
Weening, JJ
Roos, D
Kuijpers, TW
Citation: Jm. Van Den Berg et al., Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils, J LEUK BIOL, 69(3), 2001, pp. 467-473
Authors:
de Vries, E
Noordzij, JG
Kuijpers, TW
van Dongen, JJM
Citation: E. De Vries et al., Flow cytometric immunophenotyping in the diagnosis and follow-up of immunodeficient children, EUR J PED, 160(10), 2001, pp. 583-591
Authors:
van Woensel, JBM
Biezeveld, MH
Alders, AMB
Eerenberg, AJM
Endert, E
Hack, EC
von Rosenstiel, IA
Kuijpers, TW
Citation: Jbm. Van Woensel et al., Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease, J INFEC DIS, 184(12), 2001, pp. 1532-1537
Authors:
van den Berg, JM
Mul, FPJ
Schippers, E
Weening, JJ
Roos, D
Kuijpers, TW
Citation: Jm. Van Den Berg et al., beta(1) integrin activation on human neutrophils promotes beta(2) integrin-mediated adhesion to fibronectin, EUR J IMMUN, 31(1), 2001, pp. 276-284
Authors:
Kuijpers, TW
Van den Berg, JM
Tool, ATJ
Roos, D
Citation: Tw. Kuijpers et al., The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase, CLIN EXP IM, 123(3), 2001, pp. 412-420
Authors:
Teeling, JL
Bleeker, WK
Rigter, GMM
van Rooijen, N
Kuijpers, TW
Hack, CE
Citation: Jl. Teeling et al., Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages studies in a rat model, BR J HAEM, 112(4), 2001, pp. 1031-1040
Authors:
Baars, PA
do Couto, LMR
Leusen, JHW
Hooibrink, B
Kuijpers, TW
Lens, SMA
van Lier, RAW
Citation: Pa. Baars et al., Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8(+)CD45RA(+)CD27(-) human T cells, J IMMUNOL, 165(4), 2000, pp. 1910-1917
Authors:
Weening, RS
De Boer, M
Kuijpers, TW
Neefjes, VME
Hack, WWM
Roos, D
Citation: Rs. Weening et al., Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease, CLIN EXP IM, 122(3), 2000, pp. 410-417
Authors:
Bleeker, WK
Teeling, JL
Verhoeven, AJ
Rigter, GMM
Agterberg, J
Tool, ATJ
Koenderman, AHL
Kuijpers, TW
Hack, CE
Citation: Wk. Bleeker et al., Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase, BLOOD, 95(5), 2000, pp. 1856-1861
Authors:
Dahlem, PG
von Rosenstiel, IA
Lam, J
Kuijpers, TW
Citation: Pg. Dahlem et al., Pulse methylprednisolone therapy for impending cardiac tamponade in immunoglobulin-resistant Kawasaki disease, INTEN CAR M, 25(10), 1999, pp. 1137-1139
Citation: Tw. Kuijpers et al., Clinical and laboratory work-up of patients with neutrophil shortage or dysfunction, J IMMUNOL M, 232(1-2), 1999, pp. 211-229
Citation: Tw. Kuijpers et T. Van Der Poll, The role of platelet-activating factor in endotoxin-related disease, ENDOTOXIN IN HEALTH AND DISEASE, 1999, pp. 449-462